Muneeb Akhtar
The US FDA registration symbolizes the highest benchmark for product safety, quality assurance, and regulatory compliance. For Indian manufacturers, it serves as a key enabler for entry into highly regulated international markets such as the United States, the European Union, and the Middle East — paving the way for accelerated global growth. For Lords Mark Industries, this achievement represents a pivotal step in its international expansion journey, broadening its export reach while contributing to India's vision of becoming a global leader in healthcare manufacturing.
Comprehensive FDA-Approved Product Portfolio
The company's FDA-approved product range spans an extensive array of healthcare categories — including medical consumables such as Cotton Crepe Bandages, Elastic Adhesive Bandages, Cannula Fixators, and Disinfectant Wet Wipes. It also encompasses orthopedic and rehabilitation aids like abdominal and rib belts, lumbar supports, cervical collars, Taylor's braces, arm slings, shoulder immobilizers, cockup splints, and knee immobilizers. Additionally, under the Lord's Joy brand, the company offers hygiene products including baby wipes, bed bath wipes, and refreshing wipes, rounding out a complete healthcare solutions lineup.
World-Class Manufacturing Infrastructure
At the core of this accomplishment lies Lords Mark Industries Ltd.'s advanced surgical manufacturing facility located in Dadra & Nagar Haveli. The plant features five integrated divisions and employs more than 100 skilled professionals, showcasing a seamless blend of precision engineering and production expertise.
The facility adheres to the 5S manufacturing system to streamline operations and improve efficiency, supported by a robust QC/QA process that includes multiple checkpoints for inspection, testing, and validation. Its infrastructure comprises five loom machines, TFO and cheese winders, warping and dyeing units, 38 stitching machines, and a fully automated elastic adhesive coating system.
This state-of-the-art unit complies with the most rigorous global quality standards, including ISO 13485:2016, WHO-GMP, CDSCO, cGMP, GLP, Indian FDA, and US FDA guidelines. Every product is crafted to meet international benchmarks for reliability, performance, and safety.
Innovative Logistics and Quality Excellence
Beyond production, Lords Mark Industries has modernized its logistics by implementing end-to-end digital integration and real-time tracking systems, ensuring precise, timely deliveries across domestic and export markets. Its predictive logistics model leverages data analytics to optimize routes, enhance packaging traceability, and reduce turnaround times. These advancements help minimize lead time, lower handling costs, and reinforce the company's reputation for reliability and on-time delivery.
The company's six-step Quality Excellence Framework adds further rigor to its operations — covering specification development, stage-wise quality checks, employee training, performance monitoring, corrective measures, and ongoing improvement. Every member of the team is trained to embody this commitment to quality, ensuring that "Hamesha Aapke Saath" is not just a tagline, but a principle embedded in daily practice.
Leadership Vision
Commenting on this achievement, Mr. Sachidanand Upadhyay, Managing Director of Lords Mark Industries Ltd., stated:
"Our goal is to make Indian-manufactured healthcare products globally recognized — offering world-class quality and affordability. The US FDA registration empowers us to fulfill this mission and extend our presence across international markets."
Under the leadership of Mr. Manav Teli, Executive Director, and with support from Mr. Niraj Oza, Business Head, Lords Mark Industries has scaled its operations, placing strong emphasis on automation, R&D-driven innovation, and sustainable production practices.
Speaking about this milestone, Mr. Manav Teli added:
"US FDA registration confirms our dedication to excellence and innovation. Through automation, strict quality controls, and advanced logistics systems, we are creating a global healthcare supply chain that is faster, transparent, and technology-driven."
Expanding Global Footprint
With this achievement, Lords Mark Industries Ltd. — which already operates its U.S. subsidiary, Lords Mark Global LLC, based in Texas — joins the elite circle of Indian healthcare manufacturers with FDA recognition, alongside esteemed names such as Sun Pharma, Cipla, Dr. Reddy's, Biocon, Meril Life Sciences, and Poly Medicure.
The establishment of its U.S. arm strengthens the company's commitment to promoting Made-in-India manufacturing while strategically expanding into the American and allied markets. India today boasts more than 700 FDA-registered facilities, a testament to the nation's leadership in producing high-quality, compliant, and cost-effective healthcare products for the world.
Muneeb Akhtar
